SCHEMBL29670932

SCHEMBL29670932

C#Cc1cccc(Nc2c(C#N)cnc3cc(OCC)c(N)cc23)c1

nearest known ligand 0.72

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.72
GAK O14976 2/20 0.72
ERBB2 P04626 12/20 0.69
STK4 Q13043 4/20 0.56
FBP1 P09467 1/20 0.55
SRC P12931 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30132269 1.00 EGFR (0.72) EGFRGAKERBB2STK4FBP1
SCHEMBL2131741 1.00 EGFR (0.72) EGFRGAKERBB2STK4FBP1
SCHEMBL22419601 0.94 EGFR (0.71) EGFRGAKERBB2STK4SRC
SCHEMBL2943166 0.90 EGFR (0.85) EGFRGAKERBB2SRC
SCHEMBL3593063 0.90 EGFR (0.86) EGFRGAKERBB2SRC
SCHEMBL20584416 0.87 EGFR (0.71) EGFRGAKERBB2STK4SRC
SCHEMBL1897571 0.87 EGFR (0.85) EGFRGAKERBB2STK4
SCHEMBL29670935 0.85 EGFR (0.67) EGFRGAKERBB2STK4
SCHEMBL28487491 0.85 EGFR (0.67) EGFRGAKERBB2STK4
SCHEMBL14855133 0.84 EGFR (0.66) EGFRGAKERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111875539-B Preparation method of EGFR (epidermal growth factor receptor) molecular targeted antitumor drug 苏中药业集团股份有限公司 2022-06-21 CN claimed
CN-111875539-B Preparation method of EGFR (epidermal growth factor receptor) molecular targeted antitumor drug 苏中药业集团股份有限公司 2022-06-21 CN disclosed